Skip to main content
Fig. 6 | Journal of Experimental & Clinical Cancer Research

Fig. 6

From: LncMAPK6 drives MAPK6 expression and liver TIC self-renewal

Fig. 6

LncMAPK6-MAPK6 pathway can be targeted for liver TIC clearance. (a, b) 1 × 106 lncMAPK6 silenced (ASO, A) or overexpressed (oeLnc, b) were used for 1 month tumor propagation. 6 BALB/c nude mice were used for each sample. (c) 1 × 106 indicated cells were used for tumor propagation and tumor weights were examined one month later. (d) The indicated tumors were used for MAPK6 immunohistochemistry. (e, f) The indicated tumors were stained with Ki67 (e) and CD133 (f) antibodies for FACS detection. Gating strategy and indicated ratios were shown

Back to article page